Participation in clinical trials enables patients to access new treatment options. Evidence shows improved outcomes in participants compared with nonparticipants in non-small-cell, lung, breast, colorectal, and testicular cancers.
No takes yet. Share an insight, caveat, or question.
Chua et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: